Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens

García-Caballero T, Grabau D, Green A R, Gregory J, Schad A, Kohlwes E, Ellis I O, Watts S & Mollerup J (2010) Histopathology56, 472–480 Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridiz...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Caballero, Tomás, Grabau, Dorthe, Green, Andrew R, Gregory, John, Schad, Arno, Kohlwes, Elke, Ellis, Ian O, Watts, Sarah, Mollerup, Jens
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855864/
https://www.ncbi.nlm.nih.gov/pubmed/20459554
http://dx.doi.org/10.1111/j.1365-2559.2010.03503.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855864/
https://www.ncbi.nlm.nih.gov/pubmed/20459554
http://dx.doi.org/10.1111/j.1365-2559.2010.03503.x

Ejemplares similares